-
Yangtze River hits 1 billion injections!
Time of Update: 2021-11-14
Since the beginning of this year, Yangtze River has received 19 injections, covering multiple therapeutic areas such as anti-tumor drugs, anesthetics, and contrast agents .
0 Chinese Drug Evaluation DatabaseSince the beginning of this year, Yangtze River has received 19 injections, covering multiple subcategories such as anti-tumor drugs, anesthetics, and contrast agents.
-
With a series of policies vigorously boosting the development of Chinese medicine, the authentic medicinal material industry has a great opportunity
Time of Update: 2021-11-14
For example, as early as December 18, 2018, the Ministry of Agriculture and Rural Affairs of the United Nations National Drug Administration and the State Administration of Traditional Chinese Medicine jointly issued the "National Authentic Medicinal Material Production Base Construction Plan (2018-2025)", which is a guide Important documents for the development of the Chinese herbal medicine industry in the next few years are also important measures to implement the Chinese Medicine Law .
-
once a week!
Time of Update: 2021-11-14
ArticleMedicine GuanlanRecently, the Chinese drug clinical trial registration and information disclosure platform showed that Novo Nordisk has launched a trial in China to study how NNC0174-0833 (cagrilintide) can play a role in normal weight, overweight or obese Chinese population .
-
Traditional Chinese medicine decoction pieces are frequently found to be unqualified. How should pharmaceutical companies ensure quality and safety?
Time of Update: 2021-11-14
Therefore, pharmaceutical equipment companies also need to continue to carry out technological innovation, while promoting the high-quality development of traditional Chinese medicine decoction pieces, continuously improve their own competitiveness .
-
Generic drugs will remain the focus in the next ten years, and there will still be a broad market
Time of Update: 2021-11-14
Generic drugs have important economic and social benefits in reducing medical expenditures, improving the availability of medicines, and improving the level of medical services . It is understood t
-
National Medical Insurance Administration: In principle, all national drug procurement agreements should continue to carry out centralized procurement after the expiration of the agreement
Time of Update: 2021-11-14
44 The medical insurance bureaus of all provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps: In order to implement the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Drug Centralized and Volume Procurement" (Guobanfa [2021] No.
-
Announcement of the State Food and Drug Administration on the Implementation of the Application of Electronic General Technical Documents for Drugs (No. 119 of 2021)
Time of Update: 2021-11-14
The Drug Evaluation Center of the National Medical Products Administration will do a good job in the relevant technical guidance during the implementation of this announcement .
-
The National Medical Insurance Administration determines the rules for renewing contracts with volume purchases
Time of Update: 2021-11-14
All provinces, autonomous regions, municipalities directly under the Central Government, and Xinjiang Production and Construction Corps Medical Insurance Bureau: To implement the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Centralized and Mass Procurement of Drugs" (Guobanfa [2021] No.
-
Zhou Song, director of Sinopharm Accord, resigns
Time of Update: 2021-11-14
On November 2, Sinopharm unanimously announced that the company’s board of directors had recently received a written resignation report from director Zhou Song . Zhou Song applied to resign as a dire
-
Announcement of the State Drug Administration on Revising the Instructions for Oxaliplatin Preparations (No. 102 of 2021)
Time of Update: 2021-11-14
The marketing authorization holders of the above-mentioned drugs shall be in accordance with the "Administrative Measures for Drug Registration" and other relevant regulations, in accordance with the requirements for the revision of the oxaliplatin preparation instructions (see attachment), before November 22, 2021 Report to the provincial drug supervision and administration department for the record .
-
Six pharmaceutical companies invested more than 1 billion yuan in R&D in the first three quarters, showing strong innovation momentum
Time of Update: 2021-11-14
142 billion yuan According to the data of the 2021 third quarter report released by Hengrui Medicine, the R&D investment of Hengrui Medicine continues to increase this year.
-
Roche/Regeneron Ronapreve approved in Japan for preventive treatment of symptomatic COVID-19
Time of Update: 2021-11-13
Recently, Chugai Pharma, a Japanese pharmaceutical company controlled by Roche, recently announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan has approved the antibody cocktail therapy Ronapreve (casirivimab and imdevimab, formerly known as: REGN-COV2) as a new indication : Used to prevent symptomatic SARS-CoV-2 infection (COVID-19) .
-
The environmental protection storm in the pharmaceutical industry continues, and it has become an inevitable trend to accelerate the transition to "green"
Time of Update: 2021-11-13
Recently, the Shenyang Municipal Bureau of Ecology and Environment released the "Shenyang Municipality’s Second Round of Provincial-level Ecological Environmental Protection Inspectors' Rectification Plan", and the pollution problem of a pharmaceutical company was once again exposed .
-
Nian Shen Jinghua) Near Qiaokou in Wuhan
Time of Update: 2021-11-13
"Flying up into the sky" to describe this year's lithium The price of the ore is not exaggerated.
On October 26, Pilbara, one of Australia’s largest lithium concentrate producers, opened the third lithium concentrate auction, and the final auction price was set at US$2,350/ton.
-
Based on the recognition of the great value of the field, Hillhouse still has a strong position in Biomedicine
Time of Update: 2021-11-13
In the third quarter of this year, Hillhouse Capital mainly reduced positions in the secondary market, but did not increase positions, and it disappeared from such pharmaceutical companies as Kailaiying, Tigermed, and Aier Ophthalmology .
-
"Latest Breaking News" A conscience mentor who seeks to bring back blood "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
"Latest News" Mentor WeChat "Mobile Sohu.com" who invested 10 yuan and earned 100
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
"Latest Breaking News" Dafa's most powerful rebirth mentor "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
-
A dazzling presence in the pharmaceutical industry: AI pharmaceuticals
Time of Update: 2021-11-13
According to the industry, traditional biopharmaceutical companies have pain points such as long research and development cycles, high failure rates, and high costs when conducting new drug research and development.
-
"Latest Breaking News" Mentor Program Covers WeChat QQ "Mobile Sohu.com"
Time of Update: 2021-11-13
Many times we can enrich ourselves by learning various skills.
. Step 3: Kill 1 pattern is like killing all odd, all even, all small, all big, all quality, all combined with small probability.
Sometimes other people's experience will become our learning direction .
